RAPACAT trial: Rapamycin in cats with subclinical HCM

Send us Fan Mail

Dr.  Joshua Stern author of "Delayed-release rapamycin halts progression of left ventricular hypertrophy in subclinical feline hypertrophic cardiomyopathy: results of the RAPACAT trial in: Journal of the American Veterinary Medical Association - Ahead of print (avma.org)" discusses how delayed-release rapamycin may prevent or delay progressive left ventricular hypertrophy in cats with subclinical HCM. Hosted by Associate Editor Dr. Sarah Wright and Editor-in-Chief Dr. Lisa Fortier.

INTERESTED IN SUBMITTING YOUR MANUSCRIPT TO JAVMA OR AJVR?

JAVMA: https://avma.org/JAVMAAuthors

AJVR: https://avma.org/AJVRAuthors

FOLLOW US:

JAVMA:

Facebook: Journal of the American Veterinary Medical Association - JAVMA | Facebook

Instagram: JAVMA (@avma_javma) • Instagram photos and videos

Twitter: JAVMA (@AVMAJAVMA) / Twitter

AJVR: 

Facebook: American Journal of Veterinary Research - AJVR | Facebook

Instagram: AJVR (@ajvroa) • Instagram photos and videos

Twitter: AJVR (@AJVROA) / Twitter

JAVMA and AJVR LinkedIn: https://linkedin.com/company/avma-journals

#VeterinaryVertexPodcast #JAVMA #AJVR

INTERESTED IN SUBMITTING YOUR MANUSCRIPT TO JAVMA ®  OR AJVR ® ?

JAVMA ® : https://avma.org/JAVMAAuthors

AJVR ® : https://avma.org/AJVRAuthors

FOLLOW US:

JAVMA ® :

Facebook: Journal of the American Veterinary Medical Association - JAVMA | Facebook

Instagram: JAVMA (@avma_javma) • Instagram photos and videos

Twitter: JAVMA (@AVMAJAVMA) / Twitter

AJVR ® : 

Facebook: American Journal of Veterinary Research - AJVR | Facebook

Instagram: AJVR (@ajvroa) • Instagram photos and videos

Twitter: AJVR (@AJVROA) / Twitter

JAVMA ®  and AJVR ®  LinkedIn: https://linkedin.com/company/avma-journals